Drug application
ESTRADIOL VALERATE AND DIENOGEST (DIENOGEST, ESTRADIOL VALERATE)
Drugs@FDA ANDA 202349 · WATSON LABS INC
Key facts
| Drug name | ESTRADIOL VALERATE AND DIENOGEST |
|---|---|
| Active ingredients | DIENOGEST, ESTRADIOL VALERATE |
| Application type | ANDA |
| Application number | 202349 |
| Company | WATSON LABS INC |
| Dosage forms | TABLET, ORAL |
| Strength | N/A,2MG,3MG,N/A,N/A;3MG,2MG,2MG,1MG,N/A |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | May 9, 2017 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.